Gálvez Patricia, Martín Maria J, Calpena Ana C, Tamayo Juan A, Ruiz Maria A, Clares Beatriz
Andalusian Centre for Molecular Biology and Regenerative Medicine (CABIMER), Seville, Spain.
Pharm Res. 2014 Dec;31(12):3515-28. doi: 10.1007/s11095-014-1438-8. Epub 2014 Jun 25.
A critical limiting factor of cell therapy is the short life of the stem cells. In this study, glucose containing alginate microspheres were developed and characterized to provide a sustained release system prolonging the viability of human mesenchymal stem cells (hMSCs) in a suspension for clinical application.
The glucose microspheres were satisfactorily elaborated with alginate by emulsification/internal gelation method. Particle size was evaluated by light diffraction and optical microscopy. Shape and surface texture by scanning electron microscopy (SEM). Zeta potential, infrared spectra and release studies were also conducted. Also, rheological properties and stability of hMSCs suspensions with microspheres were tested. The viability of hMSCs was determined by trypan blue dye exclusion staining.
Microspheres of 86.62 μm, spherical shaped and -32.54 mV zeta potential with excellent stability, good encapsulation efficiency and providing an exponential release of glucose were obtained. hMSCs had better survival rate when they were packed with glucose microspheres. Microspheres maintained the aseptic conditions of the cell suspension without rheological, morphological or immunophenotypic disturbances on hMSCs.
Developed microspheres were able to enhance the functionality of hMSC suspension. This strategy could be broadly applied to various therapeutic approaches in which prolonged viability of cells is necessary.
细胞治疗的一个关键限制因素是干细胞寿命短。在本研究中,制备并表征了含葡萄糖的海藻酸盐微球,以提供一种缓释系统,延长人间充质干细胞(hMSCs)在悬浮液中的活力,用于临床应用。
采用乳化/内部凝胶化法用海藻酸盐成功制备了葡萄糖微球。通过光衍射和光学显微镜评估粒径。通过扫描电子显微镜(SEM)观察形状和表面纹理。还进行了zeta电位、红外光谱和释放研究。此外,测试了含微球的hMSCs悬浮液的流变学性质和稳定性。通过台盼蓝拒染法测定hMSCs的活力。
获得了粒径为86.62μm、呈球形、zeta电位为-32.54mV的微球,具有优异的稳定性、良好的包封效率并能实现葡萄糖的指数释放。当hMSCs与葡萄糖微球包装在一起时,其存活率更高。微球保持了细胞悬浮液的无菌条件,且对hMSCs没有流变学、形态学或免疫表型干扰。
所制备的微球能够增强hMSC悬浮液的功能。该策略可广泛应用于各种需要延长细胞活力的治疗方法。